Log in to save to my catalogue

Serious reaction reminders: sodium valproate and fetal malformations

Serious reaction reminders: sodium valproate and fetal malformations

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_rmit_collectionsjats_10_3316_informit_561399458842463

Serious reaction reminders: sodium valproate and fetal malformations

About this item

Full title

Serious reaction reminders: sodium valproate and fetal malformations

Journal title

Australian adverse drug reactions bulletin, 2009-04, Vol.28 (2), p.6-7

Formats

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Sodium valproate is well known to cause fetal malformations and is classified as a Pregnancy Category D drug. Teratogenic risk appears to be dose-dependent and increases markedly at doses greater than 1100 mg/day in the first trimester. (non-author abstract)

Alternative Titles

Full title

Serious reaction reminders: sodium valproate and fetal malformations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_rmit_collectionsjats_10_3316_informit_561399458842463

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_rmit_collectionsjats_10_3316_informit_561399458842463

Other Identifiers

ISSN

0812-3837

How to access this item